# Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients

> **NCT03440892** · — · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 2500 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** methotrexate
- **DRUG:** sulfasalazine
- **DRUG:** abatacept
- **DRUG:** tocilizumab
- **DRUG:** tofacitinib/baricitinib

## Key facts

- **NCT ID:** NCT03440892
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03440892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03440892, "Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03440892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*